Back to Search Start Over

CD38high/HLA-DR+ CD8+ T cells as potential biomarker of hemophagocytic lymphohistiocytosis secondary to visceral Leishmania infection.

Authors :
Mastrolia, Maria Vincenza
Boscia, Silvia
Galli, Luisa
Lodi, Lorenzo
Pisano, Laura
Maccora, Ilaria
Ricci, Silvia
Pagnini, Ilaria
Marrani, Edoardo
Azzari, Chiara
Simonini, Gabriele
Source :
European Journal of Pediatrics; Mar2023, Vol. 182 Issue 3, p1429-1432, 4p, 1 Graph
Publication Year :
2023

Abstract

Leishmaniasis is a cause of infection associated with hemophagocytic lymphohistiocytosis (HLH). The measurement of the CD8<superscript>+</superscript> CD38<superscript>high</superscript>/HLA-DR<superscript>+</superscript> T cells in children presenting with acute onset of shock and multisystem organ failure represents an important parameter to distinguish HLH from sepsis or healthy control. Conclusion: We report a case series of 4 Italian children suffering from HLH secondary to visceral Leishmaniasis in which the lymphocyte subset assay suggests a potential role of CD38<superscript>high</superscript>/HLA-DR<superscript>+</superscript> CD8<superscript>+</superscript> T cells as HLH diagnostic biomarkers. What is Known: • Visceral Leishmaniasis is a well-known cause of infection associated with hemophagocytic lymphohistiocytosis (HLH). • The measurement of the CD8<superscript>+</superscript>CD38<superscript>high</superscript>/HLA-DR<superscript>+</superscript>T cells in children presenting with acute onset of shock and multisystem organ failure represents an important diagnostically useful parameter to readily distinguish HLH from sepsis or healthy controls. What is New: • We report a case series of 4 Italian children suffering from HLH secondary to visceral Leishmaniasis in which the lymphocyte subset assay suggests a potential role of CD38<superscript>high</superscript>/HLA-DR<superscript>+</superscript>CD8<superscript>+</superscript>T cells as HLH diagnostic biomarker. • The flow cytometry assay, performed at the disease onset before starting treatment, revealed a mean percentage value of CD38 cells of 36.95% among CD8<superscript>+</superscript>T cells. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
03406199
Volume :
182
Issue :
3
Database :
Complementary Index
Journal :
European Journal of Pediatrics
Publication Type :
Academic Journal
Accession number :
162508257
Full Text :
https://doi.org/10.1007/s00431-022-04789-x